
NMAC Applauds FDA Approval of Lenacapavir for PrEP | Urges Equitable Access Amid Federal Rollbacks
WASHINGTON, DC, UNITED STATES, June 19, 2025 /EINPresswire.com/ -- The U.S. Food and Drug Administration approval of Lenacapavir as a twice-yearly injectable PrEP marks a breakthrough in HIV prevention, especially for communities hardest hit by the …